News
Taxotere improves survival in head-neck cancer - Reuters
www.reuters.com
Adding the Sanofi-Aventis cancer drug Taxotere to standard chemotherapyhelps people with head and neck cancer live more than threeyears longer, two teams of...
The Billion-Dollar “Dud”: Merck's HPV Vaccine Takes a Licking But ...
www.cbsnews.com
by Jim Edwards “Clearly, boys need to be vaccinated,” says Marshall Posner, the incoming medical director of head and neck cancer at Mt. Sinai Medical Center in New York. “I want my kids to be vaccinated. I don't see a downside to these vaccines.” ...
Yes, Oncologists Have a Weird Sense of Humor
scienceblogs.com
Clinical investigator, Marshall Posner, MD, Medical Director of the Head and Neck Oncology Program at Dana-Farber Cancer Institute in Boston, said "The TAX 324 trial found that the addition of Taxotere to standard induction chemotherapy ...
Evolving Roles of Robert Maki, MD, PhD, and Marshall Posner, MD, in ...
alumni.icahn.mssm.edu
We are pleased to announce the appointment of Robert Maki, MD, PhD, as Director of the Cancer Clinical Trials Office at Icahn School of ...
sorted by relevance / date